Day: October 27, 2021

ST. LOUIS, Oct. 27, 2021 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported net income available to common shareholders of $182.7 million, or $1.54 per diluted common share on net revenues of $1.1 billion for the three months ended September 30, 2021, compared with net income available to common shareholders of $110.6 million, or $0.97 per diluted common share (1) on net revenues of $883.3 million for the third quarter of 2020. For the three months ended September 30, 2021, the Company reported non-GAAP net income available to common shareholders of $195.7 million, or $1.65 per diluted common share. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said “The third quarter’s net revenue and EPS were the second highest in our history as both operating segments, Global Wealth Management and Institutional...

Concurrent dosing of MGMT-modified gamma-delta T cells with Temozolomide (TMZ) demonstrated a significant survival benefit across multiple models of high-grade glioma MGMT-modified gamma-delta T cells are engineered to survive chemotherapy and form the basis of IN8bio’s Drug Resistant Immunotherapy (DRI) technology These results, published online in the Nature portfolio journal Scientific Reports (DOI: https://doi.org/10.1038/s41598-021-00536-8), provide significant preclinical support for the clinical development of DRI DRI with a concurrent TMZ dosing regimen is currently being evaluated in a Phase 1 clinical trial in glioblastoma multiforme (GBM) at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB) NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical...

RIDGEFIELD, Conn., Oct. 27, 2021 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States and Canada, today reported financial results for its third quarter ended September 24, 2021. Financial highlights for the third quarter of 2021:Net sales increased 90.7% to $484.3 million for the third quarter of 2021 from $254.0 million for the third quarter of 2020. GAAP net income was $3.5 million, or $0.09 per diluted share, for the third quarter of 2021 compared to net loss of $11.4 million, or $(0.31) per diluted share, in the third quarter of 2020. Adjusted EPS1 was $0.12 for the third quarter of 2021 compared to $(0.38) for the third quarter of 2020. Adjusted EBITDA1 was $23.4 million for the third quarter of 2021 compared to negative...

NEW HAVEN, Conn., Oct. 27, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its third quarter 2021 financial results on Wednesday, November 10, 2021 before the open of the U.S. financial markets. BioXcel Therapeutics’ management team will also host a conference call and webcast at 8:30 AM ET to discuss the Company’s financial results and to provide a general business update.Conference Call & Webcast DetailsDate/Time:Domestic:International: Wednesday, November 10, 2021 at 8:30 AM Eastern Time877-407-5795201-689-8722   The webcast and the accompanying materials will be accessible* under “News/Events”...

MONACO, Oct. 27, 2021 (GLOBE NEWSWIRE) — Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the third quarter (“Q3 2021”) and nine-months ended September 30, 2021. I. PROFITABILITYQ3 2021 Net Income available to common stockholders of $107.4 million compared to $17.4 million in Q3 2020. Q3 2021 Earnings per Share of $0.87 compared to $0.14 in Q3 2020. Q3 2021 Adjusted Net Income available to common stockholders(1) of $81.5 million compared to $26.7 million in Q3 2020. Q3 2021 Adjusted Earnings per Share(1) of $0.66 compared to $0.22 in Q3 2020.II. SALE AND PURCHASE ACTIVITYDelivery of another 20 dry bulk vessels (total delivered fleet of 34 vessels), with three additional vessels expected to be delivered within 2021. Delivery of the 2009-built, 4,578 TEU containership...

The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population MALVERN, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the United States.   COVAXIN™ is a whole-virion inactivated COVID-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades. The Phase 3 trial proposed in the IND is designed to establish whether the immune response...

THORNTON, CO, Oct. 27, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Ascent Solar Technologies, Inc. (OTCMKTS: ASTI), a developer and manufacturer of state-of-the-art, lightweight and flexible thin-film photovoltaic (PV) solutions (“Ascent” or the “Company”), announces that the Company is a proud recipient of a selective Innovation Award at the Defense TechConnect (DTC) Conference, held on October 18-21, 2021, in National Harbor, MD.  DTC is an event focused on connecting top US Department of Defense (DoD) offices and industry scouts with the world’s best innovations. It brings together defense, private industry, federal agency, and academic leadership to accelerate state-of-the-art technology solutions for the military and the interest of national security. This year’s key focus areas included energy, climate, cyber,...

Figure 1Flow Rates versus Time for Cluster C1Figure 2Estimated number of dewatering wells for Cluster C1 over timeMONTREAL, Oct. 27, 2021 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals“) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to provide positive results from the ongoing hydrogeological modelling and its application to dewatering costs at the Pine Point Project, located in the NWT, Canada. A new 3D hydrogeological model was created and has yielded significant reductions in the estimated water inflow rates into the proposed open pit and shallow underground mines, relative to the estimates in the July 2020 PEA study. Reduction in dewatering costs was estimated for a portion of the project, specifically in a sub-zone of the Main...

Acquisition expected to drive strong global growth for Viccarbe and adds to Steelcase’s growing portfolio of social and collaborative furnishings, supporting a strategy to provide the widest range of aesthetic choices and price points in the industry. GRAND RAPIDS, Mich., Oct. 27, 2021 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today announced it has acquired Viccarbe Habitat, S.L., a Spanish designer of contemporary furniture for high-performance collaborative and social spaces. The acquisition builds on more than 10 years of successful partnership between Viccarbe and Steelcase. Founded in Valencia in 2000 by Victor Carrasco and Daniel Benedito, Viccarbe’s heritage and Spanish roots are a key part of its design story and brand positioning. “We inspire Mediterranean experiences in collaborative spaces through the creation of...